Alphatec (ATEC)
(Delayed Data from NSDQ)
$9.41 USD
+0.54 (6.09%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $9.35 -0.06 (-0.64%) 6:36 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.41 USD
+0.54 (6.09%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $9.35 -0.06 (-0.64%) 6:36 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Zacks News
Strength Seen in Alphatec (ATEC): Can Its 12.1% Jump Turn into More Strength?
by Zacks Equity Research
Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LENSAR, Inc. (LNSR) Moves 13.5% Higher: Will This Strength Last?
by Zacks Equity Research
LENSAR, Inc. (LNSR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of -29.03% and 0.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Orthofix (OFIX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Orthofix (OFIX) delivered earnings and revenue surprises of 107.69% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ViewRay (VRAY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 2.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nevro (NVRO) delivered earnings and revenue surprises of 0% and 0.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Idexx Laboratories (IDXX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Idexx (IDXX) delivered earnings and revenue surprises of 13.17% and 2.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Alphatec (ATEC) Moves 12.8% Higher: Will This Strength Last?
by Zacks Equity Research
Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of -86.96% and 2.37%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Alphatec (ATEC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 20th
by Zacks Equity Research
GEL, WWD, IBIO, SI, and ATEC have been added to the Zacks Rank #5 (Strong Sell) List on October 20, 2021.
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of -50.00% and 21.58%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Alphatec (ATEC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 15th
by Zacks Equity Research
ATEC, DRNA, AG, PAX, and AUPH have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2021
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of 15.79% and 0.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Alphatec (ATEC) Surges 11.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of 4.35% and 0.19%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health's (OPK) BioReference Extends Digital Health Access
by Zacks Equity Research
OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.
Zacks.com featured highlights include: Alphatec, Fidus Investment and Blue Bird Corp
by Zacks Equity Research
Zacks.com featured highlights include: Alphatec, Fidus Investment and Blue Bird Corp
4 Affordable Breakout Stocks for Stunning Returns
by Nitish Marwah
Selecting breakout stocks continues to be one of the most popular methods utilized by active investors.
3 Stocks to Watch Out for Earnings Acceleration in 2021
by Tirthankar Chakraborty
It's prudent for investors to keep an eye on a few stocks like Alphatec Holdings (ATEC), Fidus Investment (FDUS) and Blue Bird (BLBD) for stellar earnings acceleration.
5 Little-Known Stocks Under $20 Analysts Recommend Buying
by Anindya Barman
We recommend a few lesser-known stocks that hold promise for high returns this year. ADTN, AMEH, ATEC, DFIN and DGII fit the bill.
Analysts Estimate Alphatec (ATEC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Alphatec (ATEC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alphatec (ATEC) Looks Good: Stock Adds 5.8% in Session
by Zacks Equity Research
Alphatec (ATEC) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.